3 min read
The API Registration Process in the Philippines is governed by the Philippine Food and Drug Administration (FDA) through a structured Regulatory framework designed to ensure the quality, safety, and compliance of Active Pharmaceutical Ingredients intended for human use.
Pharmaceutical companies planning Philippines API registration must comply with FDA licensing requirements, ASEAN Common Technical Dossier (ACTD) standards, and post-approval obligations before APIs can be marketed as raw materials in the country. Understanding the Regulatory pathway, documentation expectations, and submission procedures is essential for achieving efficient approvals and maintaining long-term compliance in the Philippine pharmaceutical market.
API Registration Process in the Philippines
Below is a comprehensive, stepwise outline of the Active Pharmaceutical Ingredient (API) registration process in the Philippines, grounded strictly in the latest regulations and authoritative documents from the Philippine Food and Drug Administration (FDA):
Step 1: Applicant Eligibility and Preparation
- Only a duly licensed drug manufacturer, trader, or distributor (importer/exporter) holding a valid License to Operate (LTO) from the FDA may file an application for API registration.
- APIs must be intended for marketing as raw materials to local pharmaceutical manufacturing companies. Registration is NOT required if the API is imported or manufactured by the pharmaceutical product manufacturer exclusively for in-house production (not for sale or marketing as raw material).
Step 2: Filing the Registration Application
- The application must be submitted via the FDA’s digital eServices portal (manual paper submission is being phased out in favor of digitalization, per FDA's modernization efforts).
- The applicant must submit a declaration under oath attesting to the truthfulness and accuracy of all information.
Step 3: Compilation of Required Documentation
Technical documentation should be prepared in accordance with FDA requirements and where applicable, ACTD harmonized principle and typically includes:
- Duly accomplished Integrated Application Form (excel and pdf).
- Letter of Authorization (if applicable).
- Valid GMP certificate for the API manufacturer.
- Specifications and validated methods for the API, as prescribed in a recognized pharmacopeia or justified with scientific data if deviating or if the substance is not pharmacopoeial .
- Certificate of analysis for each batch of API.
- Manufacturing process description.
- Stability study results.
- Proof of payment of prescribed fees.
Companies preparing submissions should ensure alignment with FDA Philippines API requirements and regional documentation expectations.
Step 4: Pre-Submission Consultation (Optional)
- Applicants may seek pre-submission consultation with the FDA for complex or novel APIs before formal submission.
This approach may help applicants address Regulatory gaps early in the API Registration Process in the Philippines.
Step 5: Submission and Receipt of Application
- Application is reviewed for completeness upon submission.
- Incomplete applications are flagged, and applicants are informed accordingly.
Step 6: Evaluation and Assessment
- The FDA screens the application for Regulatory compliance, product quality, and adherence to pharmacopeial or justified in-house specifications.
- Additional queries or requests for clarification may be communicated to the applicant during evaluation.
Step 7: Final Decision and Issuance of Certificate
- Upon successful evaluation, FDA issues corresponding authorization documents in accordance with applicable regulations governing pharmaceutical raw materials and APIs.
- The new API is then included in the FDA Drug Registry.
Step 8: Post-Approval Obligations
- Any new information affecting the API’s benefit-risk profile must be reported to the FDA immediately.
- Upon request, reference standards may need to be submitted to support analytical validation.
Timelines and Fees
- Specific timelines and fee structures are regularly updated in the FDA Citizen's Charter and through FDA Circulars. Applicants are advised to consult the latest edition at: https://www.fda.gov.ph/citizens-charter-2024/
Key Regulatory Notes
- APIs registered in the Philippines must comply with quality standards reflected in acknowledged pharmacopeias (USP, BP, EP, JP, etc.).
- Registration requirements do NOT apply to APIs imported/manufactured solely for internal use in own drug product manufacture (not for sale as API).
Conclusion
The API Registration Process in the Philippines requires careful Regulatory planning, compliant documentation preparation, and continuous coordination with FDA requirements throughout the product lifecycle. From applicant eligibility and dossier preparation to evaluation, approval, and post-marketing obligations, pharmaceutical companies must ensure strict adherence to Regulatory expectations to avoid delays and maintain compliance.
With extensive expertise in ASEAN Regulatory affairs, dossier preparation, and market entry support, Freyr Solutions assists organizations with end-to-end Philippines API registration, Regulatory strategy, and submission readiness aligned with evolving FDA Philippines API requirements.
Click here to know more about our services: Medicinal Products Regulatory Support in Philippines | Freyr - Global Regulatory Solutions and Services Company
To learn more about how Freyr can support your Regulatory needs in Philippines write to us at sales@freyrsolutions.com.
